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In Canada, results from the Canadian Tobacco Use Monitoring Survey (CTUMS) have shown a decline in the prevalence of current smokers from 25% in 1999 to 18% in 2008. 3 However, this decline varied by region, age group, and sex. It is unclear how this trend has affected the burden of smoking on mortality and morbidity.
A number of countries, including Canada, have used attributable fractions (AFs) to estimate the number of deaths caused by smoking, more often referred to as smoking-attributable mortality (SAM). [4] [5] [6] [7] [8] [9] AFs describe the fraction of deaths an exposure is responsible for or alternatively, the proportion of disease that would not occur if the exposure were removed. Some of these countries have extended this methodology to hospitalization data to estimate smoking-attributable hospitalization (SAH). 4, 8, 10 The Cost of Substance Abuse in Canada report (CSAC) estimated that smoking was responsible for over 37 thousand deaths and 339 thousand hospitalizations in 2002 (estimates for British Columbia: SAM 4,616; SAH 34,501). 4 In comparison, it was estimated that alcohol was responsible for over 4 thousand deaths and almost 200 thousand hospitalizations, and illicit drug use accounted for 1,700 deaths and over 60 thousand hospitalizations.
In British Columbia (BC), a comprehensive substance use monitoring project (www.aodmonitoring.ca) is being undertaken with the goal of building a system to provide timely data on risky patterns of substance use and related harms as a means of supporting more effective policy-making, facilitating research on substance use and informing public debate. 11 One component of the project is tracking alcohol-, drug-, and smoking-attributable mortality and hospitalization. This component is currently using the AFs that were used in the CSAC report. This allows for estimates by health region, age, gender, and disease condition.
Given that the AFs used in the CSAC report were based on 2003 smoking prevalence estimates of the Canadian population 4 (current smoker prevalence = 23%), the availability of annual BC smoking prevalence from the Canadian Tobacco Use Monitoring Survey (CTUMS) presents an opportunity to more accurately estimate SAM and SAH in BC. BC has the lowest prevalence of current smokers among all provinces in Canada, so use of the Canadian prevalence would likely overestimate SAM and SAH. In addition, using a static set of AFs to estimate SAM and SAH over time does not take into account changes in prevalence over time. The prevalence of current smokers in BC has decreased from 20% in 2000 to 14% in 2007. 3 Using current smoking data for BC, the objectives of this study are to: 1) adjust the AFs used in the CSAC report for each year of BC smoking prevalence data from 2002 to 2007; 2) apply the adjusted AFs to the respective annual BC mortality and hospitalization data to calculate the number of SAM and SAH; 3) and calculate standardized rates of SAM and SAH by gender, health region and disease category. 
METHODS

Data sources
Mortality and Hospital Data
Attributable Fractions and Calculation of SAM
Smoking AFs for chronic diseases were calculated using the formula:
k = total levels of exposure i = exposure category with baseline exposure or no exposure i=0 RR(i) = relative risk at exposure level i compared to no consumption P(i) = prevalence of the i th category of exposure.
AFs were calculated by age groups and sex. The age-and sexspecific AFs were then multiplied with the mortality and hospitalization data to estimate SAM and SAH.
The AF for fire injury was calculated using direct estimates of smoking involvement. 12 This number was used for all estimates. 
Prevalence of Smoking
Relative Risks
Relative risks were taken from the CSAC report. Briefly, a list of causal health conditions attributable to smoking was compiled (Table 1) . A comprehensive search of meta-analyses was performed for each disease category and its risk relationship with smoking. Where possible, the most detailed dose-response relative risks were used.
Rate Calculation
Rates were age-and sex-standardized using the direct method and the 2001 age 15 and over BC population as the standard.
RESULTS
Among active smoking adults 15 years of age and older, there were an estimated 4,851 deaths and 25,314 hospitalizations attributed to smoking in BC in 2007 (Tables 2 and 3 Table 3 .
Smoking Rates of tobacco-attributable mortality and hospitalizations by health services delivery areas (HSDA) for BC population age 15+, 2007
Geographically, the Northern health authority (HA) has consistently held the highest rates of SAM and SAH over the course of the study period, while Vancouver Coastal HA had the lowest. With the largest population, Fraser HA has the largest number of SAM and SAH, with about 5 times more deaths and 4 times more hospitalizations than the Northern HA. Figure 1 displays the SAM and SAH rates by BC health services delivery area (HSDA) in 2006. The areas of high SAM rates generally correspond with areas of high SAH rates. The metro areas of Vancouver and Victoria have among the lowest rates of SAM and SAH.
Almost half of the deaths in 2007 were from cancer (47.8%), with lung cancer accounting for 75% of all smoking-related cancer deaths. Mortality rates by condition can be found in Table 1 . Respiratory diseases accounted for 26.6% and cardiovascular disease accounted for 24.8% of smoking-related deaths. The top causes of SAM in 2007 were lung cancer (1,727 deaths), chronic obstructive pulmonary disease (COPD) (1,079), ischemic heart disease (526), and cerebrovascular disease (312). Together, these conditions accounted for 75% of all SAM.
In 2007, smoking caused 263 cardiovascular, 194 respiratory, and 146 cancer hospitalizations per 100,000 adults (Table 1) . COPD, ischemic heart disease, bladder cancer, lung cancer and cardiac arrhythmia were the top five causes of SAH, accounting for 70% of all SAH.
DISCUSSION
Despite the decrease of current smokers from 2002 to 2007 in BC, the harms associated with tobacco smoking have not shown the same dramatic decrease. In fact, only since 2006 have there been signs that the rates of SAM and SAH have started to decrease. This is likely due to the latency between smoking and health outcome. 13 In Canada, smoking prevalence has declined since the late 1960s; however, lung cancer rates did not start declining until about 1990.
14 The timeframe of this study is too short to determine which stage of the epidemic curve BC is currently at; however, with continuous monitoring, this will become clear over several years. Another contributing factor to the discrepancy was the increase in the number of 'experimental' users, those who tried a few cigarettes and then for whatever reason stopped. These users moved from being never-smokers to former smokers, artificially increasing their risk of smoking-related harms. A study found that redefining former smokers as having smoked at least 100 cigarettes in a lifetime could decrease SAM estimates by 5%. 15 It has not been determined which definition would produce the most accurate measurement.
In comparison with the SAM estimates produced by BC Vital Statistics in their annual reports, 16 our SAM estimates were 21-26% lower each year over the six-year period for the same age range. The relative risks used by BC Vital Statistics were taken from the American Cancer Society's Cancer Prevention Study II (CPS II). The CPS II has been criticized for not having a nationally representative sample and for not adjusting for potential confounding factors. 17, 18 Studies that estimated SAM using relative risks derived from a more representative US sample found that their estimates were between 16% and 40% lower than those derived from using the CPS II. 17 Our estimates are also based on more detailed exposure and relative risk categorization.
There were considerable differences in SAM and SAH rates between health regions in BC, with the Northern HA having over 40% more deaths and 70% more hospitalizations than Vancouver Coastal HA. Northern HA has the highest prevalence of current smokers compared with the other HAs. 19 The high rates in Northern HA are not confined to one HSDA, nor are the low rates in Vancouver Coastal HA. Thompson Cariboo Shuswap HSDA of Interior HA and Fraser East of Fraser HA both have noticeably higher SAM and SAH rates than the other HSDA areas in their respective region.
Limitations
Although AFs can be used to theoretically determine the number of deaths and hospitalizations caused by smoking, there is currently no way to determine whether these estimates hold in real life. We cannot directly link smoking as a causal factor solely on the basis of diagnostic codes. There are other methodological issues that can impact SAM and SAH estimates, such as changes in exposure measurement, exposure and relative risk categorization, or relative risk estimates. 15 However, our methodology is consistent with past Canadian studies of the same nature. The study does not include the harms related to second-hand smoke (passive smokers) or to maternal smoking. Both make up a relatively small fraction of SAM and SAH. Although AFs were adjusted using BC smoking prevalence, there are regional variations of smoking prevalence within BC. The SAM and SAH estimates would be an overestimate in low smoking prevalence regions and an underestimate in high smoking prevalence regions.
Despite potential issues with the methodology, these estimates play an important role in public health. They inform the public of the harms associated with smoking, help researchers identify highrisk areas and evaluate smoking reduction programs, and provide policy-makers with evidence of the effectiveness of policies. The methods are adaptable to other provinces and only require administrative data. Using attributable fractions adjusted for annual smoking prevalence to estimate SAM has been shown to be comparable to estimates derived from physician reports of tobaccocontributing deaths.
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CONCLUSION
Smoking still presents a substantial human and economic burden in BC and in Canada. There is some indication that the recent trend is downwards, but with the long latency period between smoking and health outcome, long-term and ongoing follow-up is needed to see if this trend is sustained. The presence of the BC Alcohol and Other Drug Monitoring Project will allow for continued surveillance of emerging trends. Areas in BC with higher rates should be targeted for appropriate tobacco prevention and cessation programs. This methodology can be used by other provinces to allow comparisons between provinces and to observe trends over time by demographic and geographic characteristics. Mots clés : tabagisme; mortalité; morbidité; fraction étiologique du risque; Colombie-Britannique
